甾体激素对C6细胞摄取甘氨酸的快速作用

目的 :探讨甾体激素对C6细胞摄取甘氨酸快速作用的非基因组织机制。方法 :应用液体闪烁技术 ,通过检测C6细胞在加入了甾体激素和 /或其它试剂后摄入标记甘氨酸量的改变 ,确定甾体激素的作用。结果 :C6细胞高亲合力的甘氨酸依赖于钠离子和氯离子。皮质酮 ,孕酮 ,地塞米松可快速抑制这种摄取 ,雌二醇 ,脱氧皮质酮无显著的抑制作用 ,表明甾体激素作用有特异性。皮质酮的作用在 10 4 -8～ 10 -6 mmol/L范围内效应与浓度成正相关。皮质酮偶联牛血清蛋白后作用依然存在。RU38486 能部分阻断皮质酮的效应。细胞外液钙离子缺乏时皮质酮的作用基本消失。结论 :虽然皮质酮 ,孕酮 ,地塞米松神经胶质细胞和神经元摄取甘氨酸的快速作用不一样 ,但均是非基因组机制。     

甘氨酸和γ-氨基丁酸对小鼠游离脊髓的初级传入终末兴奋性的作用

本工作在正常离体小鼠(天龄10—15d)脊髓进行。实验结果表明:电刺激邻近记录电极的背根,微电泳GABA及GABA的协同剂Thip、Thiomuscimol和甘氨酸(Glycine)均能引起小鼠脊髓单一初级传入纤维终末的兴奋阈值下降,兴奋性增高,说明终末发生了去极化的变化。同时电泳荷包牡丹碱(Bicuculline)能逆转GABA及其协同剂的去极化作用,但对Glycine的去极化作用无效。而士的宁(Strychnine)能逆转Glycine的去极化作用,对GABA的去极化作用无效。说明在小鼠脊髓初级传入终末存在GABA_A受体及Glycine受体,而且在传入终末区Glycine受体类型可能与脊髓内其它部位的相同。     

不同氮源对球形棕囊藻生长的影响

采用实验室培养的方法比较了6种不同氮源-硝态氮、尿素、甘氨酸、精氨酸、谷氨酸、腺嘌呤对典型赤潮藻球形棕囊藻(Phaeocystis globosa)生长的影响。结果表明,6种氮源均能不同程度地促进球形棕囊藻的生长,但比生长速率和光合作用效率具有显著差异性。将球形棕囊藻在不同浓度氮源下的最大比生长速率分别拟合Monod方程,得出球形棕囊藻在硝态氮、尿素、甘氨酸、精氨酸、谷氨酸和腺嘌呤等6种氮源下的最大比生长率分别为1.05,1.17,0.82,0.87,1.09,0.90d^-1,相应的半饱和常数分别为9.132,23.758,85.519,7.104,23.94,10.959μmol/L。其中,高氮浓度(8820μmol/L)下腺嘌呤对球型棕囊藻的生长具有显著抑制作用。相比较而言,球形棕囊藻对甘氨酸的亲和力最高。当硝态氮、尿素、甘氨酸、精氨酸、谷氨酸和腺嘌呤的浓度分别为8820,882,882,8820,882,0.441μmol/L时,球形棕囊藻的最大光合效率(Fv/Fm)分别为0.619,0.620,0.579,0.595,0.648,0.667。由此可见,氮源对球形棕囊藻的生长和光合作用具有显著影响;球形棕囊藻能够利用多种无机和有机氮源,与其它仅能利用无机氮源的浮游植物相比,更具有竞争优势。     

高效液相色谱法测定大黄素在Caco-2细胞中的摄取

目的:采用反相高效液相色谱法,观察大黄素在Caco-2细胞中的摄取特点。方法:将大黄素与Caco-2细胞共同孵育,收集细胞样品,液氮反复冻融。取细胞裂解液,加入甲醇提取,提取液采用HPLC进行分析。色谱分析柱为C18柱(250mm×4．6mm,5μm,Diamonsil),流动相组成为85%乙腈及15%水(含0．1%乙酸),流速1ml·min-1,进样量20μl,柱温25℃,3D模式采集数据。结果:检测Caco-2细胞中大黄素的工作曲线的回归方程为Y=0．278x 0．148(Y=0．9996,n=5),线性范围为0．037～4．8μmol·L-1,最低检测浓度为0．018μmol·L-1。当细胞中大黄素的浓度为0．05、2和8．5μg·ml-1时,回收率分别为(101．3±7．3)%、(96．7±3．0)%和(98．7±2．1)%(n=5);相应的日内标准偏差分别为0．25%、2．9%和1．4%;相应的日间标准偏差分别为2．3%、5．6%和6．3%。大黄素在Caco-2细胞中的摄取达峰时间为10分钟,峰浓度为108．56±11．57 nmol/L·mg·protein,10分钟后Caco-2细胞中大黄素的含量迅速下降。浓度处于2-50μM之间时,Caco-2细胞对大黄素的摄取量呈线性增加,浓度达50μM后,随着剂量的增加大黄素的摄取量变化不明显。结论:大黄素可被Caco-2细胞迅速摄取,随着剂量的增加,大黄素在Caco-2细胞中的摄取存在饱和现象。     

家兔延髓腹侧防御反应相关神经元

实验在25只乌拉坦(700m/kg)、氯醛糖(35mg/kg)麻醉,肌肉麻痹,人工呼吸的家兔上进行。第一组16只家兔中,单或双脉冲刺激下丘脑和中脑防御反应区,在延髓腹侧记录刺激所兴奋的单位。大部分单位分布于网状巨细胞核腹侧α部。52％的单位有自发放电活动。用阈下强度同时刺激下丘脑和中脑,97％单位有兴奋反应,提示家兔下丘脑和中脑防御反应区在延髓腹侧有聚合投射。第二组9只家兔中,在延髓腹表面单侧应用甘氨酸滤纸片或电凝损毁时,血压轻度下降,刺激下丘脑和中脑防御反应区引起的升压反应也部分被阻断。双侧应用甘氨酸或损毁,血压下降到脊动物水平,升压反应几乎完全被阻断。上述结果提示家兔延髓腹侧神经元在维持正常血压水平和在中继防御反应传出通路中起重要作用。     

氮磷营养限制影响三角褐指藻光合无机碳利用和碳酸酐酶活性

以海洋硅藻三角褐指藻为实验材料, 研究了不同氮磷比培养对其光合无机碳利用和碳酸酐酶活性的影响, 结果显示三角褐指藻生长速率在N:P=16:1时最大, 高于或低于16:1时明显下降, 表明其最适生长受到氮磷的限制。氮限制(N:P=4:1或1:1)导致叶绿素a含量分别下降30.1% 和47.6%, 磷限制(N:P=64:1或256:1)下降39.1%和52.4%, 但氮或磷限制对叶绿素c含量并没有明显影响。不同营养水平培养对光饱和光合速率具有明显的影响, 与营养充足培养相比, 在严重氮磷限制(N:P=1:1或256:1)培养下光饱和光合速率分别下降39.7%和48.0%, 光合效率与暗呼吸速率也明显下降。在氮磷限制培养下藻细胞pH补偿点明显下降; K0.5CO2值在磷限制下降低30%, 表明磷限制有助于提高细胞对CO2的亲和力, 但氮限制并没有明显影响。在氮磷限制培养的细胞反应液中Fe (CN)63-浓度下降速率较慢, 表明在氮磷限制环境中生长的细胞质膜氧化还原能力明显低于营养充足条件下生长的细胞。氮磷限制也导致胞内、外碳酸酐酶活性明显下降, 其中在氮限制下胞外碳酸酐酶活性分别下降50%和37.5%, 在磷限制下下降22.3%和42.1%。严重的氮(N:P=1:1)或磷(N:P=256:1)限制导致胞内碳酸酐酶活性下降36.5%和42.9%。研究结果表明, 三角褐指藻细胞在氮磷营养限制的环境中, 可以通过调节叶绿素含量、无机碳的利用方式和碳酸酐酶的活性以维持适度的生长。       

缺血-再灌注过程中心肌肌浆网钙摄取和Ca~(2 )-ATPase活性的变化

本实验用离体大鼠心脏Langendorff灌流模型,观察缺血及缺血——再灌注对大鼠心肌肌浆网[SR]钙转运功能的影响。结果表明:缺血25min引起SR钙摄取初速率下降,摄取量降低;缺血40min,使其进一步加重。缺血25min后再灌注15min,SR的钙转运功能进一步降低,与缺血40min后果类似;同时SR上的Ca~(2 )-ATPase活性也显著降低。用不同pH的灌流液进行再灌注,对SR钙转运功能的障碍无显著影响。这提示:心肌缺血可引起SR的钙转运功能障碍,并随缺血时间的延长而加重;再灌注加重缺血造成的SR功能的损伤。偏酸或偏碱的K-H液再灌注均不能改善SR钙转运功能的抑制,表明pH变化不是缺血-再灌注时引起SR功能障碍的重要因素。     

低毒兴奋效应模拟热量限制调节酵母转运体基因表达及脂质代谢

【目的】已知H2O2介导的线粒体低毒兴奋效应(Mitohormesis)能模拟热量限制延长酵母寿命,但未知两者是否存在共同作用机理。【方法】利用依时菌落计数法测定酿酒酵母时序寿命(CLS),采用微阵列芯片分析ATP结合盒(ABC)转运体基因表达谱及脂质代谢模式的转变,通过酶学测定法比较超氧化物歧化酶(SOD)活性的动态变化。【结果】经热量限制、H2O2、青蒿琥酯处理后,酵母CLS有不同程度延长,细胞解毒相关ABC转运体基因表达均下调或不变,促进长链脂肪酸运输的过氧化物酶体膜ABC转运体基因以及加速固醇摄取的质膜ABC转运体基因表达则显著上调。相应地,脂质分解(如脂肪酸β-氧化)基因表达上调,脂质合成(如脂肪酸延伸及去饱和)基因表达则下调。不同处理组中催化线粒体H2O2生成的Mn-SOD活性提高,导致催化H2O2降解及转变的抗氧化酶基因表达上调。【结论】低毒兴奋效应及热量限制在酵母中发挥延寿作用,既有赖于抗氧化酶催化的活性氧(ROS)清除反应,也取决于ABC转运体介导的脂质转运及后续的脂质分解及再利用。     

谷氨酸转运体对癫痫持续状态大鼠突触可塑性的影响

探讨了在大鼠癫痫持续状态模型,谷氨酸转运体功能改变对突触可塑性的影响.健康成年雄性Wistar大鼠((304.06±13.79)g)随机分为5组,短期癫痫实验组(SE)及其对照组(SC),长期癫痫实验组(LE)及其对照组(LC),健康对照组(Sham).匹鲁卡品皮下注射(25 mg/kg)建立癫痫模型,建模14天后SE和LE组大鼠右侧海马内注射谷氨酸转运体抑制剂TBOA(7.5 nmol,lμ1),SC和LC组注射相同剂量的人工脑脊液.注射药物2 h后,SE和SC组检测脑电图(EEG):药物注射后2周,LJ巳和LC组检测内嗅区前穿通纤维-海马齿状回(PP-DG)长时程增强(LTP)和EEG.电生理学检测后动物灌流取脑做Fluoro-Jade-B染色.结果表明:脑电功率谱分析,SE组theta波段能量较sc组明显下降(P＜0.05),LE组与其对照Lc组相比,EEG的也theta波段能量无明显差异(P＞0.05);LTP检测显示.LE组与对照LC组相比,兴奋性突触后电位(EPSP)斜率升高(P＜0.01);Fluoro-Jade-B染色显示,LE组与对照LC组相比,给予TBOA 2周后细胞变性明显增加.结果提示,癫痫持续状态后,海马神经元损伤,TBOA导致谷氨酸转运体功能障碍,加重癫痫所至神经元损伤,对海马区突触可塑性产生影响.     

缺氧对鼠视网膜Müller细胞GLAST和GS表达及功能的影响

研究了缺氧对鼠视网膜Müller细胞谷氨酸转运体(L-glutamate/L-aspartate transporter,GLAST)和谷氨酰胺合成酶(glutamine synthetase,GS)表达的影响,及对谷氨酸摄取的作用.采用出生3～7天的小鼠视网膜组织进行Müller细胞培养,采用125μmol/L的氯化钴(CoCl2)溶液分别进行缺氧干预6、12、24、48和72 h,不加CoCl2溶液培养的Müller细胞为正常对照.采用RT-PCR法、Western blot法和免疫细胞化学染色法检测GLAST和GS的表达,并检测谷氨酸摄取及细胞凋亡情况.结果显示,缺氧早期GLAST表达较正常对照组增强(P<0.001),CoCl2溶液干预12 h后达到最强(P<0.05),之后逐渐降低.CoCl2溶液干预72 h后GLAST表达与正常对照组相比无明显差异(P>0.05).而缺氧也使GS的表达较正常对照组增加(P<0.001),CoCl2溶液干预48 h后GS表达最强(P<0.001),之后开始下降.缺氧促进Müller细胞对谷氨酸的摄取,CoCl2溶液干预48 h后L-[3,4-3H]-谷氨酸的摄取量最大(P<0.005),之后开始下降.CoCl2溶液干预后,Müller细胞死亡数较正常对照组无明显差异(P>0.05).结果表明,在一定时间范围内缺氧能够增强Müller细胞GLAST及GS的表达,增加谷氨酸的摄取.但持续缺氧最终会引起Müller细胞功能失代偿,从而导致谷氨酸的代谢能力降低.     

Glycine is taken up through GLYT1 and GLYT2 transporters into mouse spinal cord axon terminals and causes vesicular and carrier-mediated release of its proposed co-transmitter GABA

Glycine and GABA are likely co-transmitters in the spinal cord. Their possible interactions in presynaptic terminals have, however, not been investigated. We studied the effects of glycine on GABA release using superfused mouse spinal cord synaptosomes. Glycine concentration dependently elicited [(3)H]GABA release which was insensitive to strychnine or 5,7-dichlorokynurenic acid, but was Na(+) dependent and sensitive to the glycine uptake blocker glycyldodecylamide. The glycine effect was external Ca(2+) independent, but was reduced when intraterminal Ca(2+) was chelated with 1,2-bis-(2-aminophenoxy)ethane-N,N,N',N'-tetracetic acid or depleted with thapsigargin, or when vesicular storage was impaired with bafilomycin. Glycine-induced [(3)H]GABA release was prevented, in part, by blocking GABA transport. The glycine effect was halved by sarcosine, a GLYT1 substrate/inhibitor, or by amoxapine, a GLYT2 blocker, and abolished by a mixture of the two. The sensitivity to sarcosine, used as a transporter inhibitor or substrate, persisted in synaptosomes prelabelled with [(3)H]GABA in the presence of beta-alanine, excluding major gliasome involvement. To conclude, in mice spinal cord, transporters for glycine (both GLYT1 and GLYT2) and for GABA coexist on the same axon terminals. Activation of the glycine transporters elicits GABA release, partly by internal Ca(2+)-dependent exocytosis and partly by transporter reversal.     

Molecular biology of glycinergic neurotransmission

Glycine is a major inhibitory neurotransmitter in the spinal cord and brainstem of vertebrates. Glycine is accumulated into synaptic vesicles by a proton-coupled transport system and released to the synaptic cleft after depolarization of the presynaptic terminal. The inhibitory action of glycine is mediated by pentameric glycine receptors (GlyR) that belong to the ligand-gated ion channel superfamily. The synaptic action of glycine is terminated by two sodium- and chloride-coupled transporters, GLYT1 and GLYT2, located in the glial plasma membrane and in the presynaptic terminals, respectively. Dysfunction of inhibitory glycinergic neurotransmission is associated with several forms of inherited mammalian myoclonus. In addition, glycine could participate in excitatory neurotransmission by modulating the activity of the NMDA subtype of glutamate receptor. In this article, we discuss recent progress in our understanding of the molecular mechanisms that underlie the physiology and pathology of glycinergic neurotransmission.     

Glycinergic nerve endings in hippocampus and spinal cord release glycine by different mechanisms in response to identical depolarizing stimuli

Studies on hippocampal glycine release are extremely rare. We here investigated release from mouse hippocampus glycinergic terminals selectively pre-labelled with [³H]glycine through transporters of the GLYT2 type. Purified synaptosomes were incubated with [³H]glycine in the presence of the GLYT1 blocker NFPS to abolish uptake (∼ 30%) through GLYT1. The non-GLYT1-mediated uptake was entirely sensitive to the GLYT2 blocker Org25543. Depolarization during superfusion with high-K⁺ (15–50 mmol/L) provoked overflows totally dependent on external Ca²⁺, whereas in the spinal cord the 35 or 50 mmol/L KCl-evoked overflow (higher than that in hippocampus) was only partly dependent on extraterminal Ca²⁺. In the hippocampus, the Ca²⁺-dependent 4-aminopyridine (1 mmol/L)-evoked overflow was five-fold lower than that in spinal cord. The component of the 10 μmol/L veratridine-induced overflow dependent on external Ca²⁺ was higher in the hippocampus than that in spinal cord, although the total overflow in the hippocampus was only half of that in the spinal cord. Part of the veratridine-evoked hippocampal overflow occurred by GLYT2 reversal and part by bafilomycin A₁-sensitive exocytosis dependent on cytosolic Ca²⁺ generated through the mitochondrial Na⁺/Ca²⁺ exchanger. As glycine sites on NMDA receptors are normally not saturated, understanding mechanisms of glycine release should facilitate pharmacological modulation of NMDA receptor function.     

Determination of the Equilibrium Dissociation Constants and Number of Glycine Binding Sites in Several Areas of the Rat Central Nervous System, Using a Sodium-Independent System

Parameters affecting the binding of [3H]glycine to membrane fractions isolated from the cerebral cortex, midbrain, cerebellum, medulla oblongata, and spinal cord of the rat were investigated in a Na+-free medium. A [3H]glycine binding assay was established in which the binding was specific, saturable, pH-sensitive, and reversible. Conditions were chosen in an effort to minimize binding to glycine uptake sites. From data on specific [3H]glycine binding Scatchard plots were prepared and the KD and Bmax values were calculated. Two glycine binding sites (high and low affinity) were identified only in the medulla (KD: 44, 211 nM; Bmax: 361, 1076 fmol/mg protein) and spinal cord (KD: 19, 104 nM; Bmax: 105, 486 fmol/mg protein). The ranges of the KD and Bmax values for the other three areas studied were 59 to 144 nM and 882 to 3401 fmol/mg protein, respectively. When the glycine content of each area, expressed as fmol/neuron, was plotted against the respective KD (high affinity), a negative correlation was found (r = --0.90; p less than 0.05). A similar negative correlation was found between the glycine content and Bmax (r = --0.88; p less than 0.05). Hill plots indicated a slope of essentially 1.0 for all areas. GABA, taurine, strychnine, diazepam, bicuculline, and imipramine had little or no effect on [3H]glycine binding.     

Uptake of Glycine into Synaptic Vesicles Isolated from Rat Spinal Cord

Glycine was taken up by a synaptic vesicle fraction from spinal cord in a Mg-ATP-dependent manner. The accumulation of glycine was inhibited by carbonyl cyanide-m-chlorophenylhydrazone (CCCP) and nigericin, agents known to destroy the proton gradient across the vesicle membrane. Vesicular uptake of glycine was clearly different from synaptosomal uptake, with respect to both the affinity constant and the effect of Na+, ATP, CCCP, and temperature. Oligomycin and strychnine did not inhibit the vesicular uptake, showing that neither mitochondrial H(+)-ATPase nor binding to strychnine-sensitive glycine receptors was involved. It is suggested that the vesicular uptake of glycine is driven by a proton gradient generated by a Mg2(+)-ATPase. A low concentration of Cl- had little effect on the uptake of glycine, whereas the uptake of glutamate in the same experiment was highly stimulated. High concentrations of gamma-amino-n-butyric acid and beta-alanine inhibited vesicular glycine uptake, but glutamate did not. Accumulation of glycine was found to be fourfold higher in a spinal cord synaptic vesicle fraction than in a vesicle fraction from cerebral cortex.     

Transport activities and expression patterns of glycine transporters 1 and 2 in the developing murine brain stem and spinal cord

Glycine serves as a neurotransmitter in spinal cord and brain stem, where it activates inhibitory glycine receptors. In addition, it serves as an essential co-agonist of excitatory N-methyl-d-aspartate receptors. In the central nervous system, extracellular glycine concentrations are regulated by two specific glycine transporters (GlyTs), GlyT1 and GlyT2. Here, we determined the relative transport activities and protein levels of GlyT1 and GlyT2 in membrane preparations from mouse brain stem and spinal cord at different developmental stages. We report that early postnatally (up to postnatal day P5) GlyT1 is the predominant transporter isoform responsible for a major fraction of the GlyT-mediated [(3)H]glycine uptake. At later stages (≥ P10), however, the transport activity and expression of GlyT2 increases, and in membrane fractions from adult mice both GlyTs contribute about equally to glycine uptake. These alterations in the activities and expression profiles of the GlyTs suggest that the contributions of GlyT1 and GlyT2 to the regulation of extracellular glycine concentrations at glycinergic synapses changes during development.     

Mechanisms of [(3)H]glycine release from mouse spinal cord synaptosomes selectively labeled through GLYT2 transporters

Glycine release has been rarely studied. The aim of this work was to characterize the release of the amino acid from spinal cord glycinergic nerve endings selectively pre-labeled through glycine transporters of the GLYT2 type. Purified mouse spinal cord synaptosomes were incubated with [(3)H]glycine in the presence of the GLYT1 blocker N-[(3R)-3-([1,1'-biphenyl]-4-yloxy)-3-(4-fluorophenyl)propyl]-N-methylglycine hydrochloride and exposed in superfusion to varying concentrations of KCl, 4-aminopyridine (4-AP), or veratridine. KCl (< or = 15 micromol/L), 4-AP (up to 1 mmol/L), and veratridine (< or = 0.3 micromol/L)-provoked [(3)H]glycine release by external Ca2+-dependent, botulinum toxin C(1)-sensitive, exocytosis. The overflows evoked by higher concentrations of K+ or veratridine involved external Ca2+-independent mechanisms of different nature. Only the overflow evoked by 3 or 10 micromol/L veratridine occurred totally (3 micromol/L) or in part (10 micromol/L) by transporter reversal, being sensitive to the GLYT2 blockers 4-benzyloxy-3,5-dimethoxy-N-[1-(dimethylaminociclopentyl)-methyl] benzamide or O-[(2-benzyloxyphenyl-3-flurophenyl)methyl]-l-serine; in contrast, the external Ca2+-independent [(3)H]glycine overflow provoked by 50 mmol/L K+ was transporter-independent. This component of K+-evoked overflow and the GLYT2-independent portion of the 10 micromol/L veratridine-evoked overflow, were largely sensitive to the vesicle depletor bafilomycin or BAPTA-AM and were prevented by blocking the mitochondrial Na+/Ca2+ exchanger with 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one, indicating the involvement of exocytosis triggered by intraterminal mitochondrial Ca2+ ions.     

Glycine-specific synapses in rat spinal cord. Identification by electron microscope autoradiography

Glycine, an inhibitory transmitter in spinal cord, is taken up into specific nerve terminals by means of a unique high-affinity uptake system. In this study, [3H]glycine was directly microinjected into rat ventral horn in vivo and electron microscope autoradiography used to localize the label in various anatomic compartments. Quantiative analysis showed that [3H]glycine labeled a high proportion of axosomatic and axodendritic synapses which presumably act to inhibit spinal motor neurons.     

GLYCINE UPTAKE IN RAT CENTRAL NERVOUS SYSTEM SLICES AND HOMOGENATES: EVIDENCE FOR DIFFERENT UPTAKE SYSTEMS IN SPINAL CORD AND CEREBRAL CORTEX

Abstract— Evidence is presented that glycine is taken up by two different transport systems in rat CNS tissue slices; one system has relatively low affinity for glycine (K_m = 300 μ m ) and predominates in cerebral cortex, cerebellum and mid-brain, the other has a higher affinity for glycine (K_m = 40 μ m ) and is detectable only in spinal cord, medulla and pons. The low affinity transport system appears to be shared by other small neutral amino acids, whereas the high affinity system is very specific for glycine. Both transport systems were shown to be present in particles in homogenates of CNS tissue by incubation with glycine in vitro , and subcellular fractionation studies suggested that synaptosomes were partly responsible for such uptake. Various substances were tested as inhibitors of the high affinity uptake system for glycine in spinal cord slices; the most potent inhibitors were p -chloro-mercuriphenylsulphonate, N -ethylmaleimide, chlorpromazine, imipramine, desipramine, hydrazinoacetic acid and haloperidol. No competitive inhibitors of the high affinity glycine uptake were found. It is suggested that the high affinity transport system is associated with inhibitory synapses where glycine is a transmitter.     

Molecular basis for substrate discrimination by glycine transporters

Glycine is an inhibitory neurotransmitter in the spinal cord and brain stem, where it acts on strychnine-sensitive glycine receptors, and is also an excitatory neurotransmitter throughout the brain and spinal cord, where it acts on the N-methyl-d-aspartate family of receptors. There are two Na(+)/Cl(-)-dependent glycine transporters, GLYT1 and GLYT2, which control extracellular glycine concentrations and these transporters show differences in substrate selectivity and blocker sensitivity. A bacterial Na(+)-dependent leucine transporter (LeuT(Aa)) has recently been crystallized and its structure determined. When the amino acid residues within the leucine binding site of LeuT(Aa) are aligned with residues of the two glycine transporters there are a number of identical residues and also some key differences. In this report, we demonstrate that the LeuT(Aa) structure represents a good working model of the Na(+)/Cl(-)-dependent neurotransmitters and that differences in substrate selectivity can be attributed to a single difference of a glycine residue in transmembrane domain 6 of GLYT1 for a serine residue at the corresponding position of GLYT2.